Clinical Trials Browser

INDUSTRY × Lung Neoplasms × infigratinib × Clear all

NCT01004224 2019-10-04

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Phase 1 Completed

GenitourinaryThoracic

Urinary Bladder Neoplasms, Lung Neoplasms